Results 111 to 120 of about 6,639,215 (265)

Bifidobacterium Lactobacillus Triple Viable Alleviates Slow Transit Constipation by Regulating Gut Microbiota and Metabolism

open access: yesJournal of Gastroenterology and Hepatology, Volume 40, Issue 6, Page 1561-1573, June 2025.
ABSTRACT Background Gut microbiota plays a crucial role in the pathogenesis and treatment of functional constipation (FC). The aim of this study was to explore the therapeutic effects of Bifidobacterium Lactobacillus triple viable on slow transit constipation (STC).
Mei Luo   +4 more
wiley   +1 more source

Primary sclerosing cholangitis-inflammatory bowel disease: Epidemiology, mortality, and impact of diagnostic sequence. [PDF]

open access: yesJHEP Rep
Leung KK   +9 more
europepmc   +1 more source

Natural History of Idiosyncratic Drug‐Induced Liver Injury and Prognostic Models

open access: yesLiver International, Volume 45, Issue 6, June 2025.
ABSTRACT Background and Aims: Drug‐induced liver injury (DILI) remains a leading cause of acute liver failure worldwide. Drugs such as isoniazid, alone or in combination with other anti‐tuberculosis drugs, as well as a growing number of herbal and complementary medicines, have been implicated in most cases of acute liver failure in registry studies ...
Harshad C. Devarbhavi, Raúl J. Andrade
wiley   +1 more source

Anti-integrin αvβ6 autoantibody in primary sclerosing cholangitis: a Japanese nationwide study. [PDF]

open access: yesJ Gastroenterol
Yasuda M   +27 more
europepmc   +1 more source

Liver transplantation [PDF]

open access: yes, 1991
Gordon, RD   +3 more
core  

Home - About - Disclaimer - Privacy